Definition of Serum Ribonucleoprotein Composition and its Regulation and Function
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function
批准号:
8719066
负责人:
THOMAS TUSCHL
金额:
$142.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2018-08-31
关键词:
AffectAgeAmyloidAntibodiesArchivesAutoantigensAutoimmune DiseasesAutoimmunityB-LymphocytesBenchmarkingBiogenesisBiological MarkersBlood CirculationBody FluidsCatalogingCatalogsCellsClinicalCollaborationsComplexCore FacilityCytoplasmic GranulesDNADepositionDevelopmentDiseaseEndoribonucleasesFamily memberFoundationsFutureGenderHarvestHealthHomeostasisHumanImmuneImmune responseImmunityImmunologic ReceptorsInclusion BodiesIndividualLeadMammalsMediatingModelingMolecularMonitorMutationMyopathyNatural ImmunityNeurodegenerative DisordersPatientsPattern recognition receptorPlayProcessProteinsRNARNA BindingRaceRecording of previous eventsRegulationResearchResearch PersonnelResearch ProposalsRheumatismRibonucleoproteinsRoleSamplingSerumSignal TransductionSolidSpecificityStressStructureSystemSystemic Lupus ErythematosusTransfer RNAbasebiological adaptation to stressclinical materialendoribonucleaseestablished cell lineextracellulargenome sequencingin vivonovelpathogenpeptide hormoneprion-liketranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Extracellular RNA (exRNA) from pathogens plays a key role as activator of innate immunity in mammals. However, the presence of host exRNA in serum and other body fluids challenges the current models of RNA based immune recognition. To understand its basis of specificity, it is important to catalog host exRNAs and their associated proteins in serum, investigate mechanisms leading to circulating ribonucleoprotein (RNP) homeostasis, and identify protein factors contributing to cellular RNA release. Genetic alterations in RNA targets or interacting proteins may contribute to imbalances in normal versus stress-triggered release of RNPs and push adaptive long-term pathogen-directed immunity towards autoimmunity. ExRNAs may also play a broader role in extracellular signaling similar to peptide hormones, which would also be captured by this experimental approach. This application brings together a team of multiple investigators with complementary expertise and history of close collaboration to build a solid foundation regarding identification, mechanism and function of extracellular RNAs and the proteins involved in their biogenesis, export, recognition, and turnover. The specific aims of the proposed project are: 1. Catalogue and quantify all classes of extracellular RNAs in human serum from normal subjects using various established and novel RNA seq approaches and examine normal variability of circulating RNA profiles within an individual, between individuals and the influence of gender, age, race, and disease. Establish a core facility for processing and archiving clinical materials (Williams, Putterman, Tuschi). 2. Determine exRNA composition in patients suffering from systemic lupus erythematosus (SLE), for whom antibodies against different classes of RBPs is a hallmark. Considering that these RBPs alter their subcellular localization upon stress and appear in stress granules with immature RNA and/or RNA targeted for turnover, we will evaluate in as much the composition of RNPs in stress granules harvested from immortalized B cells of normal and SLE subjects possesses immunostimulatory function and if these RNP granules are also released during stress (Tuschi, Putterman, Williams). 3. Develop a molecular and mechanistic understanding of stress granule formation and RNA/RNP mediated innate immune responses. Identify the RNA targets and RNP structures of autoantigens in tRNA stress responses, their turnover, and their immune receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of new antiviral methylase, protease, and helicase inhibitors of corona-, flavi-, and alphaviruses
-
批准号:10513923
-
项目类别:
-
资助金额:$570.11万
-
财政年份:2022
-
负责人:THOMAS TUSCHL
-
依托单位:
Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expression
-
批准号:10404659
-
项目类别:
-
资助金额:$49.79万
-
财政年份:2019
-
负责人:THOMAS TUSCHL
-
依托单位:
Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expression
-
批准号:10176388
-
项目类别:
-
资助金额:$50.56万
-
财政年份:2019
-
负责人:THOMAS TUSCHL
-
依托单位:
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function
-
批准号:9450828
-
项目类别:
-
资助金额:$7.71万
-
财政年份:2017
-
负责人:THOMAS TUSCHL
-
依托单位:
ExRNA composition in SLE patients and factors influencing exRNP abundance and th
-
批准号:8590490
-
项目类别:
-
资助金额:$43.64万
-
财政年份:2013
-
负责人:THOMAS TUSCHL
-
依托单位:
Elucidation of human serum RNA and RNP composition
-
批准号:8590488
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2013
-
负责人:THOMAS TUSCHL
-
依托单位:
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function
-
批准号:9124822
-
项目类别:
-
资助金额:$134.69万
-
财政年份:2013
-
负责人:THOMAS TUSCHL
-
依托单位:
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function
-
批准号:8912881
-
项目类别:
-
资助金额:$140.88万
-
财政年份:2013
-
负责人:THOMAS TUSCHL
-
依托单位:
Biochemical and structural characterization of RNA turnover processes and resolu
-
批准号:8590500
-
项目类别:
-
资助金额:$27.78万
-
财政年份:2013
-
负责人:THOMAS TUSCHL
-
依托单位:
Einstein Lupus Cohort Core
-
批准号:8590507
-
项目类别:
-
资助金额:$40.36万
-
财政年份:2013
-
负责人:THOMAS TUSCHL
-
依托单位:
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function
-
批准号:8583444
-
项目类别:
-
资助金额:$151.72万
-
财政年份:2013
-
负责人:THOMAS TUSCHL
-
依托单位:
Development of quantitative multiplex RNA in situ hybridization
-
批准号:8231314
-
项目类别:
-
资助金额:$35.36万
-
财政年份:2011
-
负责人:THOMAS TUSCHL
-
依托单位:
Development of quantitative multiplex RNA in situ hybridization
-
批准号:8444320
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2011
-
负责人:THOMAS TUSCHL
-
依托单位:
Development of quantitative multiplex RNA in situ hybridization
-
批准号:8087185
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2011
-
负责人:THOMAS TUSCHL
-
依托单位:
Development of quantitative multiplex RNA in situ hybridization
-
批准号:8815273
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2011
-
负责人:THOMAS TUSCHL
-
依托单位:
Development of quantitative multiplex RNA in situ hybridization
-
批准号:8616355
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2011
-
负责人:THOMAS TUSCHL
-
依托单位:
Developing miRNA diagnostic methods and identifying tumor regulatory networks
-
批准号:7820361
-
项目类别:
-
资助金额:$41.05万
-
财政年份:2009
-
负责人:THOMAS TUSCHL
-
依托单位:
miRNA Gene Regulatory Networks and their Role in Diseases of the Nervous System
-
批准号:7831501
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2009
-
负责人:THOMAS TUSCHL
-
依托单位:
Developing miRNA diagnostic methods and identifying tumor regulatory networks
-
批准号:7944005
-
项目类别:
-
资助金额:$42.14万
-
财政年份:2009
-
负责人:THOMAS TUSCHL
-
依托单位:
miRNA Gene Regulatory Networks and their Role in Diseases of the Nervous System
-
批准号:7600669
-
项目类别:
-
资助金额:$56.4万
-
财政年份:2007
-
负责人:THOMAS TUSCHL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: